Ribociclib exerts its therapeutic effect by interfering with cellular signals that control cell division, specifically through CDK4/6 inhibition. This action contributes to reduced tumor growth in cancers sensitive to this mechanism. Access to clear, evidence-based medical information supports better understanding of Ribociclib’s use in oncology treatment strategies. https://www.oncoespecializados.com/medicamentos/precio-kisqali-200mg-ribociclib-63-comprimidos